AngioJet血栓清除联合支架单期治疗髂静脉压迫综合征继发急性髂股深静脉血栓
本研究为多中心前瞻性非随机研究,纳入19例左侧急性髂-股总静脉DVT继发于IVCS的患者,行AngioJet流变血栓清除后支架置入。技术成功率94.7%,平均手术时间77分钟,1年一期和二期支架通畅率分别为84.2%和94.7%。单期腔内治疗可行、安全、有效。
要点
- 单期AngioJet血栓清除联合支架治疗IVCS继发急性髂股DVT技术成功率高。
- 1年一期和二期支架通畅率分别为84.2%和94.7%。
- 该方案可作为此类患者的可行治疗选择。
核心结论
- 单期AngioJet流变血栓清除联合支架置入治疗IVCS继发急性髂股DVT可行、安全且有效。
主要发现
- 技术成功率为94.7%。
- 平均手术时间为77分钟。
- 1年一期支架通畅率为84.2%,二期通畅率为94.7%。
临床怎么用
- 对于IVCS继发急性髂股DVT患者,可考虑单期行AngioJet血栓清除后支架置入。
局限性
- 研究为非随机设计,样本量较小(19例),随访时间有限(1年)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: We sought to evaluate the feasibility, safety, and effectiveness of single-stage endovascular treatment with AngioJet rheolytic thrombectomy followed by stenting for iliac vein compression syndrome (IVCS) with secondary acute iliofemoral deep vein thrombosis (DVT). METHODS: We conducted a multiple-center prospective nonrandomized study to enroll patients with left-sided acute iliac-common femoral DVT secondary to IVCS. We performed AngioJet rheolytic thrombectomy followed by stenting to evaluate the success rate, periprocedural complications, hospital stay, clinical outcomes, and stent-patency rate. RESULTS: A prospective cohort study of 19 consecutive patients diagnosed with IVCS and secondary acute iliac-common femoral DVT from October 2014 to April 2017 was conducted. The technique success rate was 94.7%, and the mean procedure time was 77 minutes. The 1-year primary and secondary patency rate was 84.2% and 94.7%, respectively. CONCLUSIONS: Single-staged endovascular treatment with AngioJet rheolytic thrombectomy and stenting is feasible, safe, and effective for IVCS with secondary acute iliofemoral DVT.
引用
- Zhu Y, Li L, Liu Z, et al. Single-Stage Treatment of AngioJet Rheolytic Thrombectomy and Stenting for Iliac Vein Compression Syndrome with Secondary Acute Iliofemoral Deep Vein Thrombosis. Ann Vasc Surg. 2019. PMID: 31075463. doi:10.1016/j.avsg.2019.02.028
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。